Molecular Templates (MTEM) stock is rocketing higher on Friday after the company got approval from the FDA for a clinical trial. More
Articles
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of the week with a breakdown of the biggest pre-market stock movers worth watching on Friday! More
This Hedge Fund Is Betting Big on Arrival Stock. Should You?
As you are unable to buy under the same terms offered to Antara Capital, consider it best to stay away from ARVL stock. More
Rivian Outlook: Signs for a RIVN Stock Revival Grow Dimmer by the Day
Before sentiment shifts fully to the bearish side, potentially sending shares to new lows, or maybe even to single-digit price levels, there's only one move to make with RIVN stock: sell/avoid. More
AI Focus Makes Nvidia Stock Interesting in 2023
NVDA stock could revisit its prior peak as analysts cheer Nvidia's quarterly results and commitment to advancing AI technology. More
The Fed’s Failure
The Fed’s “false hope” is toying with Wall Street … the latest market volatility was preventable … how Powell and Co. can save face today The Fed has an incredibly tough job, and I’d be arrogant and foolish to claim I could do it better.But now that I’ve tipped a hat toward “the high road,”… More
